B-precursor acute lymphoblastic leukemia (B-ALL) is the most common childhood tumor and
the leading cause of cancer-related death in children and young adults. The majority of B …

Acute lymphoblastic leukaemia (ALL) occurs at all ages but is the most common cancer of
childhood. The current treatment of paediatric ALL is highly successful with up to 90 …

We studied the impact of risk stratification–directed interventions for minimal residual
disease (MRD) on relapse and disease-free survival (DFS) prospectively in 814 subjects …

Although the incidence rate of acute lymphoblastic leukaemia (ALL) is slightly higher in
older than in younger adults, response rates to induction chemotherapy and survival rates …

Significant improvements have been made in the treatment of acute lymphoblastic leukemia
(ALL) during the past 2 decades, and measurement of submicroscopic (minimal) levels of …

Survival of adults with acute lymphoblastic leukemia (ALL) is inferior to that of pediatric
patients. Strategies to improve the outcome of adult population are warranted. This study …

Purpose To determine the prevalence and prognostic impact of significant acute
lymphoblastic leukemia (ALL)–related genes: CRLF2 deregulation (CRLF2-d), IGH …

To describe outcomes, treatment and prognostic factors that influence survival of adult
patients with acute lymphoblastic leukemia (ALL), who relapsed after allogeneic …

Background Deletions of IKAROS (IKZF1) frequently occur in B-cell precursor acute
lymphoblastic leukemia (B-ALL) but the mechanisms by which they influence pathogenesis …

The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute
lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi …